XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes
 3 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
9.
Income Taxes
The components of income before income taxes, as shown in the accompanying Financial Statements, consisted of the following for the three months ended March 31, 2025 and 2024:
 
    
Three Months Ended
March 31,
  
    
2025
     
2024
  
    
(Amounts in thousands)
  
Income (loss) before income taxes:
      
Domestic
    $ (2,586 )     $ (316 ) 
Foreign
      824        34  
  
 
 
     
 
 
  
Income (loss) before income taxes
    $ (1,762 )     $ (282 ) 
  
 
 
     
 
 
  
The Company has foreign subsidiaries which generate revenues from
non-U.S.-based
clients. Additionally, these subsidiaries provide services to the Company’s U.S. operations. Accordingly, the Company allocates a portion of its income (loss) to these subsidiaries based on a “transfer pricing” model and reports such income (loss) as foreign in the above table.
The provision (benefit) for income taxes, as shown in the accompanying Financial Statements, consisted of the following for the three months ended March 31, 2025 and 2024:
 
    
Three Months Ended
March 31,
  
    
2025
     
2024
  
    
(Amounts in thousands)
  
Current provision (benefit):
      
Federal
    $ (576 )     $ (224 ) 
State
      (106 )       (39 ) 
Foreign
      356        104  
  
 
 
     
 
 
  
Total current provision (benefit)
      (326 )       (159 ) 
  
 
 
     
 
 
  
Deferred provision (benefit):
      
Federal
      22        23  
State
      4        5  
Foreign
      (23 )       (83 ) 
  
 
 
     
 
 
  
Total deferred provision (benefit)
      3        (55 ) 
  
 
 
     
 
 
  
Change in valuation allowance
      —         93  
  
 
 
     
 
 
  
Total provision (benefit) for income taxes
    $ (323 )     $ (121 ) 
  
 
 
     
 
 
  
 
The reconciliation of income taxes computed using the statutory U.S. income tax rate and the provision for income taxes for the three months ended March 31, 2025 and 2024 were as follows (amounts in thousands):
 
    
Three Months Ended

March 31, 2025
    
Three Months Ended

March 31, 2024
  
Income taxes computed at the federal statutory rate
    $ (370 )       (21.0 %)    $ (59 )       (21.0 %) 
State income taxes, net of federal tax benefit
      (102 )       (5.8 %)      (10 )       (3.5 ) 
Excess tax expense (benefits) from stock options/restricted shares
      (22 )       (1.2 %)      85        30.1  
Worthless stock deduction
      —         —        (248 )       (87.9 ) 
Difference in tax rate on foreign earnings/other
      171        9.7 %      18        6.4  
Change in valuation allowance
      —         —        93        33.0  
  
 
 
     
 
 
    
 
 
     
 
 
  
   $ (323 )       (18.3 %)    $ (121 )       (42.9 %) 
  
 
 
     
 
 
    
 
 
     
 
 
  
We evaluate deferred income taxes quarterly to determine if valuation allowances are required or should be adjusted. GAAP accounting guidance requires us to assess whether valuation allowances should be established against deferred tax assets based on all available evidence, both positive and negative, using a “more likely than not” standard. Our assessment considers, among other things, the nature of cumulative losses; forecast of future profitability; the duration of statutory carry-forward periods; and tax planning alternatives. At March 31, 2025, our valuation allowance was comprised of net operating losses in Ireland
and
the United Kingdom and totaled $452,000. During the quarter ended March 31, 2024, we secured a worthless stock deduction for our dissolved Singapore entity, which allowed us to recognize a current tax deduction during the 2024 period and, accordingly, we reversed $162,000 of our valuation allowance balance. At December 31, 2024, our valuation allowance balance totaled $452,000.